Purchases and Sales Made in Q3 2021 in Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI) during Q3 2021. The information is specifically focused on institutions that hold shares of Trevi Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2021
Q3 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
3.33K+ 2.5% |
$4.3K - $7.27K
|
137K
$378K
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
BUY
|
- |
3.04K+ 142.07% |
$3.92K - $6.62K
|
5.17K
$14.3K
|
|
Nov 15, 2021
Q3 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
616+ 14.71% |
$795 - $1.34K
|
4.8K
$13.3K
|
|
Nov 15, 2021
Q3 2021
|
Harbour Investments, Inc.
Madison, WI |
BUY
|
- |
250New |
$323 - $545
|
250
$693
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
13+ 39.39% |
$16.8 - $28.3
|
46
$127
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 09, 2021
Q3 2021
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-281- 0.64% |
$362 - $613
|
43.9K
$122K
|
|
Oct 14, 2021
Q3 2021
|
Wealth Trust Axiom LLC
|
SELL
|
- |
-3K- 7.59% |
$3.87K - $6.54K
|
36.5K
$101K
|
|
Nov 15, 2021
Q3 2021
|
Alberta Investment Management Corp
Edmonton, A0 |
SELL
|
- |
-25KClosed |
$32.3K - $54.5K
|
0
$0
|
|
Nov 12, 2021
Q3 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-27.1K- 29.27% |
$35K - $59.1K
|
65.5K
$181K
|